|
1
|
Hanahan D: Hallmarks of cancer: New
Dimensions. Cancer Discov. 12:31–46. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xiao Y and Yu D: Tumor microenvironment as
a therapeutic target in cancer. Pharmacol Ther. 221:1077532021.
View Article : Google Scholar :
|
|
3
|
Liu AY, Zheng H and Ouyang G: Periostin, a
multifunctional matricellular protein in inflammatory and tumor
microenvironments. Matrix Biol. 37:150–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takeshita S, Kikuno R, Tezuka K and Amann
E: Osteoblast-specific factor 2: Cloning of a putative bone
adhesion protein with homology with the insect protein fasciclin I.
Biochem J. 294:271–278. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Horiuchi K, Amizuka N, Takeshita S,
Takamatsu H, Katsuura M, Ozawa H, Toyama Y, Bonewald LF and Kudo A:
Identification and characterization of a novel protein, periostin,
with restricted expression to periosteum and periodontal ligament
and increased expression by transforming growth factor beta. J Bone
Miner Res. 14:1239–1249. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sasaki H, Dai M, Auclair D, Fukai I,
Kiriyama M, Yamakawa Y, Fujii Y and Chen LB: Serum level of the
periostin, a homologue of an insect cell adhesion molecule, as a
prognostic marker in nonsmall cell lung carcinomas. Cancer.
92:843–848. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sasaki H, Dai M, Auclair D, Kaji M, Fukai
I, Kiriyama M, Yamakawa Y, Fujii Y and Chen LB: Serum level of the
periostin, a homologue of an insect cell adhesion molecule, in
thymoma patients. Cancer Lett. 172:37–42. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Borg TK and Markwald R: Periostin: More
than just an adhesion molecule. Circ Res. 101:230–231. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ruan K, Bao S and Ouyang G: The
multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci.
66:2219–2230. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kudo A: Periostin in fibrillogenesis for
tissue regeneration: Periostin actions inside and outside the cell.
Cell Mol Life Sci. 68:3201–3207. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu M, Fejzo MS, Anderson L, Dering J,
Ginther C, Ramos L, Gasson JC, Karlan BY and Slamon DJ: Periostin
promotes ovarian cancer angiogenesis and metastasis. Gynecol Oncol.
119:337–344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
González-González L and Alonso J:
Periostin: A matricellular protein with multiple functions in
cancer development and progression. Front Oncol. 8:2252018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Morra L and Moch H: Periostin expression
and Epithelial-mesenchymal transition in cancer: A review and an
update. Virchows Arch. 459:465–475. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Norris RA, Moreno-Rodriguez RA, Sugi Y,
Hoffman S, Amos J, Hart MM, Potts JD, Goodwin RL and Markwald RR:
Periostin regulates atrioventricular valve maturation. Dev Biol.
316:200–213. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sorocos K, Kostoulias X, Cullen-McEwen L,
Hart AH, Bertram JF and Caruana G: Expression patterns and roles of
periostin during kidney and ureter development. J Urol.
186:1537–1544. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun D, Lu J, Tian H, Li H, Chen X, Hua F,
Yang W, Yu J and Chen D: The impact of POSTN on tumor cell behavior
and the tumor microenvironment in lung adenocarcinoma. Int
Immunopharmacol. 145:1137132025. View Article : Google Scholar
|
|
17
|
Lin S, Zhou M, Cheng L, Shuai Z, Zhao M,
Jie R, Wan Q, Peng F and Ding S: Exploring the association of
POSTN+ cancer-associated fibroblasts with
Triple-negative breast cancer. Int J Biol Macromol. 268:1315602024.
View Article : Google Scholar
|
|
18
|
Kanemoto Y, Sanada F, Shibata K,
Tsunetoshi Y, Katsuragi N, Koibuchi N, Yoshinami T, Yamamoto K,
Morishita R, Taniyama Y and Shimazu K: Expression of periostin
alternative splicing variants in normal tissue and breast cancer.
Biomolecules. 14:10932024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma H, Wang J, Zhao X, Wu T, Huang Z, Chen
D, Liu Y and Ouyang G: Periostin promotes colorectal tumorigenesis
through integrin-FAK-Src Pathway-mediated YAP/TAZ activation. Cell
Rep. 30:793–806.e6. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kujawa KA, Zembala-Nożyńska E, Cortez AJ,
Kujawa T, Kupryjańczyk J and Lisowska KM: Fibronectin and periostin
as prognostic markers in ovarian cancer. Cells. 9:1492020.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pickup MW, Mouw JK and Weaver VM: The
extracellular matrix modulates the hallmarks of cancer. EMBO Rep.
15:1243–1253. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Försti A, Jin Q, Altieri A, Johansson R,
Wagner K, Enquist K, Grzybowska E, Pamula J, Pekala W, Hallmans G,
et al: Polymorphisms in the KDR and POSTN genes: Association with
breast cancer susceptibility and prognosis. Breast Cancer Res
Treat. 101:83–93. 2007. View Article : Google Scholar
|
|
23
|
Szefler S, Corren J, Silverberg JI,
Okragly A, Sun Z, Natalie CR, Zitnik R, Siu K and Blauvelt A:
Lebrikizumab decreases type 2 inflammatory biomarker levels in
patients with asthma: Data from randomized phase 3 trials (LAVOLTA
I and II). Immunotherapy. 16:1211–1216. 2024. View Article : Google Scholar
|
|
24
|
Gan C, Li M, Lu Y, Peng G, Li W, Wang H,
Peng Y, Hu Q, Wei W, Wang F, et al: SPOCK1 and POSTN are valuable
prognostic biomarkers and correlate with tumor immune infiltrates
in colorectal cancer. BMC Gastroenterol. 23:42023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jia L, Li G, Ma N, Zhang A, Zhou Y, Ren L
and Dong D: Soluble POSTN is a novel biomarker complementing CA153
and CEA for breast cancer diagnosis and metastasis prediction. BMC
Cancer. 22:7602022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Alzobaidi N, Rehman S, Naqvi M, Gulati K
and Ray A: Periostin: A potential biomarker and therapeutic target
in pulmonary diseases. J Pharm Pharm Sci. 25:137–148. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yue H, Li W, Chen R, Wang J, Lu X and Li
J: Stromal POSTN induced by TGF-β1 facilitates the migration and
invasion of ovarian cancer. Gynecol Oncol. 160:530–538. 2021.
View Article : Google Scholar
|
|
28
|
Olsson L, Hammarström ML, Israelsson A,
Lindmark G and Hammarström S: Allocating colorectal cancer patients
to different risk categories by using a Five-biomarker mRNA
combination in lymph node analysis. PLoS One. 15:e02290072020.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sugiura T, Takamatsu H, Kudo A and Amann
E: Expression and characterization of murine osteoblast-specific
factor 2 (OSF-2) in a baculovirus expression system. Protein Expr
Purif. 6:305–311. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ducy P, Geoffroy V and Karsenty G: Study
of Osteoblast-specific expression of one mouse osteocalcin gene:
Characterization of the factor binding to OSE2. Connect Tissue Res.
35:7–14. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ulstrup JC, Jeansson S, Wiker HG and
Harboe M: Relationship of secretion pattern and MPB70 homology with
osteoblast-specific factor 2 to osteitis following Mycobacterium
bovis BCG vaccination. Infect Immun. 63:672–675. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hoersch S and Andrade-Navarro MA:
Periostin shows increased evolutionary plasticity in its
alternatively spliced region. BMC Evol Biol. 10:302010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nakama T, Yoshida S, Ishikawa K, Kobayashi
Y, Abe T, Kiyonari H, Shioi G, Katsuragi N, Ishibashi T, Morishita
R and Taniyama Y: Different roles played by periostin splice
variants in retinal neovascularization. Exp Eye Res. 153:133–140.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ikeda-Iwabu Y, Taniyama Y, Katsuragi N,
Sanada F, Koibuchi N, Shibata K, Shimazu K, Rakugi H and Morishita
R: Periostin short fragment with Exon 17 via aberrant alternative
splicing is required for breast cancer growth and metastasis.
Cells. 10:8922021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
De Oliveira Macena Y, Cezar MEN, Lira CBF,
De Oliveira LBDM, Almeida TN, Costa ADAV, De Araujo BMD, de Almeida
D Junior, Dantas HM, De Mélo EC, et al: The roles of periostin
derived from Cancer-associated fibroblasts in tumor progression and
treatment response. Cancer Metastasis Rev. 44:112024. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Morra L, Rechsteiner M, Casagrande S, Duc
Luu V, Santimaria R, Diener PA, Sulser T, Kristiansen G, Schraml P,
Moch H and Soltermann A: Relevance of periostin splice variants in
renal cell carcinoma. Am J Pathol. 179:1513–1521. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kuebart T, Oezel L, Gürsoy B, Maus U,
Windolf J, Bittersohl B and Grotheer V: Periostin splice variant
expression in human osteoblasts from osteoporotic patients and its
effects on Interleukin-6 and osteoprotegerin. Int J Mol Sci.
26:9322025. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Litvin J, Selim AH, Montgomery MO, Lehmann
K, Rico MC, Devlin H, Bednarik DP and Safadi FF: Expression and
function of Periostin-isoforms in bone. J Cell Biochem.
92:1044–1061. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Viloria K and Hill NJ: Embracing the
complexity of matricellular proteins: The functional and clinical
significance of splice variation. Biomol Concepts. 7:117–132. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xiong Z, Sneiderman CT, Kuminkoski CR,
Reinheimer J, Schwegman L, Sever RE, Habib A, Hu B, Agnihotri S,
Rajasundaram D, et al: Transcript-targeted antigen mapping reveals
the potential of POSTN splicing junction epitopes in glioblastoma
immunotherapy. Genes Immun. 26:190–199. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wenhua S, Tsunematsu T, Umeda M, Tawara H,
Fujiwara N, Mouri Y, Arakaki R, Ishimaru N and Kudo Y: Cancer
Cell-derived novel periostin isoform promotes invasion in head and
neck squamous cell carcinoma. Cancer Med. 12:8510–8525. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kim CJ, Isono T, Tambe Y, Chano T, Okabe
H, Okada Y and Inoue H: Role of alternative splicing of periostin
in human bladder carcinogenesis. Int J Oncol. 32:161–169. 2008.
|
|
43
|
Kii I, Nishiyama T and Kudo A: Periostin
promotes secretion of fibronectin from the endoplasmic reticulum.
Biochem Biophys Res Commun. 470:888–893. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kii I and Ito H: Periostin and its
interacting proteins in the construction of extracellular
architectures. Cell Mol Life Sci. 74:4269–4277. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Maruhashi T, Kii I, Saito M and Kudo A:
Interaction between periostin and BMP-1 promotes proteolytic
activation of lysyl oxidase. J Biol Chem. 285:13294–13303. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Takayama I, Tanabe H, Nishiyama T, Ito H,
Amizuka N, Li M, Katsube KI, Kii I and Kudo A: Periostin is
required for matricellular localization of CCN3 in periodontal
ligament of mice. J Cell Commun Signal. 11:5–13. 2017. View Article : Google Scholar :
|
|
47
|
Orecchia P, Conte R, Balza E, Castellani
P, Borsi L, Zardi L, Mingari MC and Carnemolla B: Identification of
a novel cell binding site of periostin involved in tumour growth.
Eur J Cancer. 47:2221–2229. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Rusbjerg-Weberskov CE, Johansen ML, Nowak
JS, Otzen DE, Pedersen JS, Enghild JJ and Nielsen NS: Periostin
C-Terminal is intrinsically disordered and interacts with 143
proteins in an in vitro epidermal model of atopic dermatitis.
Biochemistry. 62:2803–2815. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang Z, Lin M, Pan Y, Liu Y, Yang C, Wu J,
Wang Y, Yan B, Zhou J, Chen R and Liu C: Periostin+ myeloid cells
improved long bone regeneration in a mechanosensitive manner. Bone
Res. 12:592024. View Article : Google Scholar :
|
|
50
|
Norris RA, Borg TK, Butcher JT, Baudino
TA, Banerjee I and Markwald RR: Neonatal and adult cardiovascular
pathophysiological remodeling and repair: Developmental role of
periostin. Ann N Y Acad Sci. 1123:30–40. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang L, Guo T, Chen Y and Bian K: The
multiple roles of periostin in Non-neoplastic disease. Cells.
12:502022. View Article : Google Scholar
|
|
52
|
Walker JT, McLeod K, Kim S, Conway SJ and
Hamilton DW: Periostin as a multifunctional modulator of the wound
healing response. Cell Tissue Res. 365:453–465. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Matsumoto H: Serum periostin: A novel
biomarker for asthma management. Allergol Int. 63:153–160. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Danielides G, Lygeros S, Kanakis M and
Naxakis S: Periostin as a biomarker in chronic rhinosinusitis: A
contemporary systematic review. Int Forum Allergy Rhinol.
12:1535–1550. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Maintz L, Welchowski T, Herrmann N, Brauer
J, Traidl-Hoffmann C, Havenith R, Müller S, Rhyner C, Dreher A,
Schmid M, et al: IL-13, periostin and dipeptidyl-peptidase-4 reveal
endotype-phenotype associations in atopic dermatitis. Allergy. Jan
17–2023. View Article : Google Scholar : Epub ahead of
print. View Article : Google Scholar
|
|
56
|
Ono J, Takai M, Kamei A, Azuma Y and
Izuhara K: Pathological roles and clinical usefulness of periostin
in type 2 inflammation and pulmonary fibrosis. Biomolecules.
11:10842021. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Mael-Ainin M, Abed A, Conway SJ, Dussaule
JC and Chatziantoniou C: Inhibition of periostin expression
protects against the development of renal inflammation and
fibrosis. J Am Soc Nephrol. 25:1724–1736. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Qiao B, Liu X, Wang B and Wei S: The role
of periostin in cardiac fibrosis. Heart Fail Rev. 29:191–206. 2024.
View Article : Google Scholar
|
|
59
|
Nuzzo PV, Buzzatti G, Ricci F, Rubagotti
A, Argellati F, Zinoli L and Boccardo F: Periostin: A novel
prognostic and therapeutic target for genitourinary cancer? Clin
Genitourin Cancer. 12:301–311. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Shao R, Bao S, Bai X, Blanchette C,
Anderson RM, Dang T, Gishizky ML, Marks JR and Wang XF: Acquired
expression of periostin by human breast cancers promotes tumor
angiogenesis through up-regulation of vascular endothelial growth
factor receptor 2 expression. Mol Cell Biol. 24:3992–4003. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Liu B, Wu T, Lin B, Liu X, Liu Y, Song G,
Fan C and Ouyang G: Periostin-TGF-β feedforward loop contributes to
tumour-stroma crosstalk in liver metastatic outgrowth of colorectal
cancer. Br J Cancer. 130:358–368. 2024. View Article : Google Scholar
|
|
62
|
Tilman G, Mattiussi M, Brasseur F, van
Baren N and Decottignies A: Human periostin gene expression in
normal tissues, tumors and melanoma: Evidences for periostin
production by both stromal and melanoma cells. Mol Cancer.
6:802007. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Zhang S, Xiao X, Yi Y, Wang X, Zhu L, Shen
Y, Lin D and Wu C: Tumor initiation and early tumorigenesis:
Molecular mechanisms and interventional targets. Signal Transduct
Target Ther. 9:1492024. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Dorafshan S, Razmi M, Safaei S, Gentilin
E, Madjd Z and Ghods R: Periostin: Biology and function in cancer.
Cancer Cell Int. 22:3152022. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Pavlova NN, Zhu J and Thompson CB: The
hallmarks of cancer metabolism: Still emerging. Cell Metab.
34:355–377. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Moniuszko T, Wincewicz A, Koda M,
Domysławska I and Sulkowski S: Role of periostin in esophageal,
gastric and colon cancer. Oncol Lett. 12:783–787. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Huang M, Fang W, Farrel A, Li L,
Chronopoulos A, Nasholm N, Cheng B, Zheng T, Yoda H, Barata MJ, et
al: ALK upregulates POSTN and WNT signaling to drive neuroblastoma.
Cell Rep. 43:1139272024. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Kikuchi Y, Kunita A, Iwata C, Komura D,
Nishiyama T, Shimazu K, Takeshita K, Shibahara J, Kii I, Morishita
Y, et al: The niche component periostin is produced by
cancer-associated fibroblasts, supporting growth of gastric cancer
through ERK activation. Am J Pathol. 184:859–870. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Hong L, Sun H, Lv X, Yang D, Zhang J and
Shi Y: Expression of periostin in the serum of NSCLC and its
function on proliferation and migration of human lung
adenocarcinoma cell line (A549) in vitro. Mol Biol Rep.
37:2285–2293. 2010. View Article : Google Scholar
|
|
70
|
Kotobuki Y, Yang L, Serada S, Tanemura A,
Yang F, Nomura S, Kudo A, Izuhara K, Murota H, Fujimoto M, et al:
Periostin accelerates human malignant melanoma progression by
modifying the melanoma microenvironment. Pigment Cell Melanoma Res.
27:630–639. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
72
|
Parker TM, Henriques V, Beltran A,
Nakshatri H and Gogna R: Cell competition and tumor heterogeneity.
Semin Cancer Biol. 63:1–10. 2020. View Article : Google Scholar
|
|
73
|
Huang Y, Hong W and Wei X: The molecular
mechanisms and therapeutic strategies of EMT in tumor progression
and metastasis. J Hematol Oncol. 15:1292022. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Lin SC, Liao YC, Chen PM, Yang YY, Wang
YH, Tung SL, Chuang CM, Sung YW, Jang TH, Chuang SE, et al:
Periostin promotes ovarian cancer metastasis by enhancing M2
macrophages and cancer-associated fibroblasts via integrin-mediated
NF-κB and TGF-β2 signaling. J Biomed Sci. 29:1092022. View Article : Google Scholar
|
|
75
|
Cheon DJ, Tong Y, Sim MS, Dering J, Berel
D, Cui X, Lester J, Beach JA, Tighiouart M, Walts AE, et al: A
Collagen-remodeling gene signature regulated by TGF-β signaling is
associated with metastasis and poor survival in serous ovarian
cancer. Clin Cancer Res. 20:711–723. 2014. View Article : Google Scholar
|
|
76
|
Park SY, Piao Y, Jeong KJ, Dong J and de
Groot JF: Periostin (POSTN) Regulates Tumor Resistance to
Antiangiogenic Therapy in Glioma Models. Mol Cancer Ther.
15:2187–2197. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Chen L, Tian X, Gong W, Sun B, Li G, Liu
D, Guo P, He Y, Chen Z, Xia Y, et al: Periostin mediates
epithelial-mesenchymal transition through the MAPK/ERK pathway in
hepatoblastoma. Cancer Biol Med. 16:89–100. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Tian Y, Choi CH, Li QK, Rahmatpanah FB,
Chen X, Kim SR, Veltri R, Chia D, Zhang Z, Mercola D and Zhang H:
Overexpression of periostin in stroma positively associated with
aggressive prostate cancer. PLoS One. 10:e01215022015. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Pauley KM and Chan EK: MicroRNAs and their
emerging roles in immunology. Ann N Y Acad Sci. 1143:226–239. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Song Y, Sun J, Xu Y, Liu J, Gao P, Chen X,
Zhao J and Wang Z: Microarray analysis of long non-coding RNAs
related to microRNA-148b in gastric cancer. Neoplasma. 64:199–208.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Hu WW, Chen PC, Chen JM, Wu YM, Liu PY, Lu
CH, Lin YF, Tang CH and Chao CC: Periostin promotes
epithelial-mesenchymal transition via the MAPK/miR-381 axis in lung
cancer. Oncotarget. 8:62248–62260. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Hu J, Tan P, Ishihara M, Bayley NA,
Schokrpur S, Reynoso JG, Zhang Y, Lim RJ, Dumitras C, Yang L, et
al: Tumor heterogeneity in VHL drives metastasis in clear cell
renal cell carcinoma. Signal Transduct Target Ther. 8:1552023.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Ueki A, Komura M, Koshino A, Wang C, Nagao
K, Homochi M, Tsukada Y, Ebi M, Ogasawara N, Tsuzuki T, et al:
Stromal POSTN enhances motility of both cancer and stromal cells
and predicts poor survival in colorectal cancer. Cancers (Basel).
15:6062023. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Miyako S, Koma YI, Nakanishi T, Tsukamoto
S, Yamanaka K, Ishihara N, Azumi Y, Urakami S, Shimizu M, Kodama T,
et al: Periostin in Cancer-associated fibroblasts promotes
esophageal squamous cell carcinoma progression by enhancing cancer
and stromal cell migration. Am J Pathol. 194:828–848. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Kim CJ, Sakamoto K, Tambe Y and Inoue H:
Opposite regulation of epithelial-to-mesenchymal transition and
cell invasiveness by periostin between prostate and bladder cancer
cells. Int J Oncol. 38:1759–1766. 2011.PubMed/NCBI
|
|
86
|
Ribatti D, Nico B, Crivellato E and Vacca
A: The structure of the vascular network of tumors. Cancer Lett.
248:18–23. 2007. View Article : Google Scholar
|
|
87
|
Ribatti D, Vacca A and Dammacco F: New
non-angiogenesis dependent pathways for tumour growth. Eur J
Cancer. 39:1835–1841. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Baril P, Gangeswaran R, Mahon PC, Caulee
K, Kocher HM, Harada T, Zhu M, Kalthoff H, Crnogorac-Jurcevic T and
Lemoine NR: Periostin promotes invasiveness and resistance of
pancreatic cancer cells to hypoxia-induced cell death: Role of the
beta4 integrin and the PI3k pathway. Oncogene. 26:2082–2094. 2007.
View Article : Google Scholar
|
|
89
|
Bao S, Ouyang G, Bai X, Huang Z, Ma C, Liu
M, Shao R, Anderson RM, Rich JN and Wang XF: Periostin potently
promotes metastatic growth of colon cancer by augmenting cell
survival via the Akt/PKB pathway. Cancer Cell. 5:329–339. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Huang Z, Byrd O, Tan S, Hu K, Knight B, Lo
G, Taylor L, Wu Y, Berchuck A and Murphy SK: Periostin facilitates
ovarian cancer recurrence by enhancing cancer stemness. Sci Rep.
13:213822023. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Mariani A, Wang C, Oberg AL, Riska SM,
Torres M, Kumka J, Multinu F, Sagar G, Roy D and Jung DB: Genes
associated with bowel metastases in ovarian cancer. Gynecol Oncol.
154:495–504. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Lozneanu L, Caruntu ID, Amalinei C,
Moscalu M, Gafton B, Marinca MV, Rusu A, Balan R and Giusca SE:
Periostin in ovarian carcinoma: From heterogeneity to prognostic
value. Folia Histochem Cytobiol. 61:1–16. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Gillot L, Lebeau A, Baudin L, Pottier C,
Louis T, Durré T, Longuespée R, Mazzucchelli G, Nizet C, Blacher S,
et al: Periostin in lymph node pre-metastatic niches governs
lymphatic endothelial cell functions and metastatic colonization.
Cell Mol Life Sci. 79:2952022. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Kudo Y, Iizuka S, Yoshida M, Nguyen PT,
Siriwardena SB, Tsunematsu T, Ohbayashi M, Ando T, Hatakeyama D,
Shibata T, et al: Periostin directly and indirectly promotes tumor
lymphangiogenesis of head and neck cancer. PLoS One. 7:e444882012.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Pistritto G, Trisciuoglio D, Ceci C,
Garufi A and D'Orazi G: Apoptosis as anticancer mechanism: Function
and dysfunction of its modulators and targeted therapeutic
strategies. Aging (Albany NY). 8:603–619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Vaghari-Tabari M, Ferns GA, Qujeq D,
Andevari AN, Sabahi Z and Moein S: Signaling, metabolism, and
cancer: An important relationship for therapeutic intervention. J
Cell Physiol. 236:5512–5532. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Morana O, Wood W and Gregory CD: The
apoptosis paradox in cancer. Int J Mol Sci. 23:13282022. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Gao L, Shay C and Teng Y: Cell death
shapes cancer immunity: Spotlighting PANoptosis. J Exp Clin Cancer
Res. 43:1682024. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Ouyang G, Liu M, Ruan K, Song G, Mao Y and
Bao S: Upregulated expression of periostin by hypoxia in
non-small-cell lung cancer cells promotes cell survival via the
Akt/PKB pathway. Cancer Lett. 281:213–219. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Erkan M, Reiser-Erkan C, Michalski CW,
Deucker S, Sauliunaite D, Streit S, Esposito I, Friess H and Kleeff
J: Cancer-stellate cell interactions perpetuate the
Hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma.
Neoplasia. 11:497–508. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Zhou W, Ke SQ, Huang Z, Flavahan W, Fang
X, Paul J, Wu L, Sloan AE, McLendon RE, Li X, et al: Periostin
secreted by glioblastoma stem cells recruits M2 Tumour-associated
macrophages and promotes malignant growth. Nat Cell Biol.
17:170–182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Wang H, Liang Y, Liu Z, Zhang R, Chao J,
Wang M, Liu M, Qiao L, Xuan Z, Zhao H and Lu L: POSTN+
cancer-associated fibroblasts determine the efficacy of
immunotherapy in hepatocellular carcinoma. J Immunother Cancer.
12:e0087212024. View Article : Google Scholar :
|
|
103
|
Jin X, Deng Q, Ye S, Liu S, Fu Y, Liu Y,
Wu G, Ouyang G and Wu T: Cancer-associated fibroblast-derived
periostin promotes papillary thyroid tumor growth through
integrin-FAK-STAT3 signaling. Theranostics. 14:3014–3028. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Muñoz-Espín D and Serrano M: Cellular
senescence: From physiology to pathology. Nat Rev Mol Cell Biol.
15:482–496. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
McHugh D, Durán I and Gil J: Senescence as
a therapeutic target in cancer and age-related diseases. Nat Rev
Drug Discov. 24:57–71. 2025. View Article : Google Scholar
|
|
106
|
Hernandez-Segura A, Nehme J and Demaria M:
Hallmarks of cellular senescence. Trends Cell Biol. 28:436–453.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Calcinotto A, Kohli J, Zagato E,
Pellegrini L, Demaria M and Alimonti A: Cellular senescence: Aging,
Cancer, and Injury. Physiol Rev. 99:1047–1078. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
de Magalhães JP: Cellular senescence in
normal physiology. Science. 384:1300–1301. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Fane M and Weeraratna AT: How the ageing
microenvironment influences tumour progression. Nat Rev Cancer.
20:89–106. 2020. View Article : Google Scholar :
|
|
110
|
D'Ambrosio M and Gil J: Reshaping of the
tumor microenvironment by cellular senescence: An opportunity for
senotherapies. Dev Cell. 58:1007–1021. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Zhu D, Chen S, Sheng P, Wang Z, Li Y and
Kang X: POSTN promotes nucleus pulposus cell senescence and
extracellular matrix metabolism via activing Wnt/β-catenin and
NF-κB signal pathway in intervertebral disc degeneration. Cell
Signal. 121:1112772024. View Article : Google Scholar
|
|
112
|
Li Q, Liu X and Wei J: Ageing related
periostin expression increase from cardiac fibroblasts promotes
cardiomyocytes senescent. Biochem Biophys Res Commun. 452:497–502.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
An JN, Kim H, Kim EN, Cho A, Cho Y, Choi
YW, Kim JH, Yang SH, Choi BS, Lim CS, et al: Effects of periostin
deficiency on kidney aging and lipid metabolism. Aging (Albany NY).
13:22649–22665. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Huang YW, Chiang MF, Ho CS, Hung PL, Hsu
MH, Lee TH, Chu LJ, Liu H, Tang P and Victor Ng W: A transcriptome
study of progeroid neurocutaneous syndrome reveals POSTN As a new
element in proline metabolic disorder. Aging Dis. 9:1043–1057.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Sun L, Zhang H and Gao P: Metabolic
reprogramming and epigenetic modifications on the path to cancer.
Protein Cell. 13:877–919. 2022. View Article : Google Scholar :
|
|
116
|
Halperin C, Hey J, Weichenhan D, Stein Y,
Mayer S, Lutsik P, Plass C and Scherz-Shouval R: Global DNA
methylation analysis of Cancer-associated fibroblasts reveals
extensive epigenetic rewiring linked with RUNX1 upregulation in
breast cancer stroma. Cancer Res. 82:4139–4152. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Kehrberg RJ, Bhyravbhatla N, Batra SK and
Kumar S: Epigenetic regulation of cancer-associated fibroblast
heterogeneity. Biochim Biophys Acta Rev Cancer. 1878:1889012023.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Albrengues J, Bertero T, Grasset E, Bonan
S, Maiel M, Bourget I, Philippe C, Herraiz Serrano C, Benamar S,
Croce O, et al: Epigenetic switch drives the conversion of
fibroblasts into proinvasive cancer-associated fibroblasts. Nat
Commun. 6:102042015. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Becker LM, O'Connell JT, Vo AP, Cain MP,
Tampe D, Bizarro L, Sugimoto H, McGow AK, Asara JM, Lovisa S, et
al: Epigenetic reprogramming of Cancer-associated fibroblasts
deregulates glucose metabolism and facilitates progression of
breast cancer. Cell Rep. 31:1077012020. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Mishra R, Haldar S, Placencio V, Madhav A,
Rohena-Rivera K, Agarwal P, Duong F, Angara B, Tripathi M, Liu Z,
et al: Stromal epigenetic alterations drive metabolic and
neuroendocrine prostate cancer reprogramming. J Clin Invest.
128:4472–4484. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Yang M, Wang B, Hou W, Zeng H, He W, Zhang
XK, Yan D, Yu H, Huang L, Pei L, et al: NAD+ metabolism enzyme NNMT
in cancer-associated fibroblasts drives tumor progression and
resistance to immunotherapy by modulating macrophages in urothelial
bladder cancer. J Immunother Cancer. 12:e0092812024. View Article : Google Scholar :
|
|
122
|
Han B, Yang X, Zhang P, Zhang Y, Tu Y, He
Z, Li Y, Yuan J, Dong Y, Hosseini DK, et al: DNA methylation
biomarkers for nasopharyngeal carcinoma. PLoS One. 15:e02305242020.
View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Tang Y, Qing C, Wang J and Zeng Z: DNA
Methylation-based diagnostic and prognostic biomarkers for
glioblastoma. Cell Transplant. 29:9636897209332412020. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Nabi-Afjadi M, Farzam F, Soltani S,
Golestani N, Asl SS, Aziziyan F, Zalpoor H, Ghasemi F, Dabirmanesh
B and Khajeh K: The association between periostin and tumor
microenvironment: A promising cancer prognostic biomarker and
therapeutic target to combat tumor progression and chemoresistance.
Cancer Cell Int. 25:3202025. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Gerarduzzi C, Hartmann U, Leask A and
Drobetsky E: The matrix revolution: Matricellular proteins and
restructuring of the cancer microenvironment. Cancer Res.
80:2705–2717. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Li Z, Pai R, Gupta S, Currenti J, Guo W,
Di Bartolomeo A, Feng H, Zhang Z, Li Z, Liu L, et al: Presence of
Onco-fetal neighborhoods in hepatocellular carcinoma is associated
with relapse and response to immunotherapy. Nat Cancer. 5:167–186.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Anand P, Kunnumakkara AB, Sundaram C,
Harikumar KB, Tharakan ST, Lai OS, Sung B and Aggarwal BB: Cancer
is a preventable disease that requires major lifestyle changes.
Pharm Res. 25:2097–2116. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Lu P, Weaver VM and Werb Z: The
extracellular matrix: A dynamic niche in cancer progression. J Cell
Biol. 196:395–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Kudo A and Kii I: Periostin function in
communication with extracellular matrices. J Cell Commun Signal.
12:301–308. 2018. View Article : Google Scholar :
|
|
130
|
Wang Z and Ouyang G: Periostin: A bridge
between cancer stem cells and their metastatic niche. Cell Stem
Cell. 10:111–112. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Celià-Terrassa T and Jolly MK: Cancer stem
cells and Epithelial-to-mesenchymal transition in cancer
metastasis. Cold Spring Harb Perspect Med. 10:a0369052020.
View Article : Google Scholar
|
|
132
|
Plaks V, Kong N and Werb Z: The cancer
stem cell niche: How essential is the niche in regulating stemness
of tumor cells? Cell Stem Cell. 16:225–238. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Babaei G, Aziz SG and Jaghi NZZ: EMT
cancer stem cells and autophagy; The three main axes of metastasis.
Biomed Pharmacother. 133:1109092021. View Article : Google Scholar
|
|
134
|
Malanchi I, Santamaria-Martínez A, Susanto
E, Peng H, Lehr HA, Delaloye JF and Huelsken J: Interactions
between cancer stem cells and their niche govern metastatic
colonization. Nature. 481:85–89. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Costa A, Kieffer Y, Scholer-Dahirel A,
Pelon F, Bourachot B, Cardon M, Sirven P, Magagna I, Fuhrmann L,
Bernard C, et al: Fibroblast heterogeneity and immunosuppressive
environment in human breast cancer. Cancer Cell. 33:463–479.e10.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Wei WF, Chen XJ, Liang LJ, Yu L, Wu XG,
Zhou CF, Wang ZC, Fan LS, Hu Z, Liang L and Wang W: Periostin+
cancer-associated fibroblasts promote lymph node metastasis by
impairing the lymphatic endothelial barriers in cervical squamous
cell carcinoma. Mol Oncol. 15:210–227. 2021. View Article : Google Scholar
|
|
137
|
Bhattacharjee S, Hamberger F, Ravichandra
A, Miller M, Nair A, Affo S, Filliol A, Chin L, Savage TM, Yin D,
et al: Tumor restriction by type I collagen opposes Tumor-promoting
effects of Cancer-associated fibroblasts. J Clin Invest.
131:e1469872021. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Han CC, Liu TY and Yin R: Biomarkers for
Cancer-associated fibroblasts. Biomark Res. 8:642020. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Oskarsson T and Massagué J: Extracellular
matrix players in metastatic niches. EMBO J. 31:254–256. 2012.
View Article : Google Scholar :
|
|
140
|
Lambert AW, Wong CK, Ozturk S, Papageorgis
P, Raghunathan R, Alekseyev Y, Gower AC, Reinhard BM, Abdolmaleky
HM and Thiagalingam S: Tumor Cell-derived periostin regulates
cytokines that maintain breast cancer stem cells. Mol Cancer Res.
14:103–113. 2016. View Article : Google Scholar :
|
|
141
|
Zhang Q, Wang C and Cliby WA:
Cancer-associated stroma significantly contributes to the
mesenchymal subtype signature of serous ovarian cancer. Gynecol
Oncol. 152:368–374. 2019. View Article : Google Scholar :
|
|
142
|
Vermeulen L, De Sousa EMF, van der Heijden
M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M, Merz C,
Rodermond H, et al: Wnt activity defines colon cancer stem cells
and is regulated by the microenvironment. Nat Cell Biol.
12:468–476. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Li P, Yang R and Gao WQ: Contributions of
Epithelial-mesenchymal transition and cancer stem cells to the
development of castration resistance of prostate cancer. Mol
Cancer. 13:552014. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Chen G, Wang Y, Zhao X, Xie XZ, Zhao JG,
Deng T, Chen ZY, Chen HB, Tong YF, Yang Z, et al: A positive
feedback loop between Periostin and TGFβ1 induces and maintains the
stemness of hepatocellular carcinoma cells via AP-2α activation. J
Exp Clin Cancer Res. 40:2182021. View Article : Google Scholar
|
|
145
|
Nowosad A, Marine JC and Karras P:
Perivascular niches: Critical hubs in cancer evolution. Trends
Cancer. 9:897–910. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Liu Z, Chen J, Ren Y, Liu S, Ba Y, Zuo A,
Luo P, Cheng Q, Xu H and Han X: Multi-stage mechanisms of tumor
metastasis and therapeutic strategies. Signal Transduct Target
Ther. 9:2702024. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Erez N: Cancer: Angiogenic awakening.
Nature. 500:37–38. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Weis SM and Cheresh DA: A wake-up call for
hibernating tumour cells. Nat Cell Biol. 15:721–723. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Ghajar CM, Peinado H, Mori H, Matei IR,
Evason KJ, Brazier H, Almeida D, Koller A, Hajjar KA, Stainier DY,
et al: The perivascular niche regulates breast tumour dormancy. Nat
Cell Biol. 15:807–817. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Lewis CE, Harney AS and Pollard JW: The
multifaceted role of perivascular macrophages in tumors. Cancer
Cell. 30:3652016. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Pietras A, Katz AM, Ekström EJ, Wee B,
Halliday JJ, Pitter KL, Werbeck JL, Amankulor NM, Huse JT and
Holland EC: Osteopontin-CD44 signaling in the glioma perivascular
niche enhances cancer stem cell phenotypes and promotes aggressive
tumor growth. Cell Stem Cell. 14:357–369. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Shi Y, Ping YF, Zhang X and Bian XW:
Hostile takeover: Glioma stem cells recruit TAMs to support tumor
progression. Cell Stem Cell. 16:219–220. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Liu Y and Cao X: Characteristics and
Significance of the Pre-metastatic Niche. Cancer Cell. 30:668–681.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Li Y, Zheng Y, Tan X, Du Y, Wei Y and Liu
S: Extracellular vesicle-mediated pre-metastatic niche formation
via altering host microenvironments. Front Immunol. 15:13673732024.
View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Peinado H, Zhang H, Matei IR, Costa-Silva
B, Hoshino A, Rodrigues G, Psaila B, Kaplan RN, Bromberg JF, Kang
Y, et al: Pre-metastatic niches: Organ-specific homes for
metastases. Nat Rev Cancer. 17:302–317. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Kong J, Tian H, Zhang F, Zhang Z, Li J,
Liu X, Li X, Liu J, Li X, Jin D, et al: Extracellular vesicles of
carcinoma-associated fibroblasts creates a pre-metastatic niche in
the lung through activating fibroblasts. Mol Cancer. 18:1752019.
View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Wang X, Jian Q, Zhang Z, Gu J, Wang X and
Wang Y: Effect of tumor-derived extracellular vesicle-shuttled
lncRNA MALAT1 on proliferation, invasion and metastasis of
triple-negative breast cancer by regulating macrophage M2
polarization via the POSTN/Hippo/YAP axis. Transl Oncol.
49:1020762024. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Ji Q, Zhou L, Sui H, Yang L, Wu X, Song Q,
Jia R, Li R, Sun J, Wang Z, et al: Primary tumors release
ITGBL1-rich extracellular vesicles to promote distal metastatic
tumor growth through fibroblast-niche formation. Nat Commun.
11:12112020. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Pitt JM, Marabelle A, Eggermont A, Soria
JC, Kroemer G and Zitvogel L: Targeting the tumor microenvironment:
Removing obstruction to anticancer immune responses and
immunotherapy. Ann Oncol. 27:1482–1492. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Fukuda K, Sugihara E, Ohta S, Izuhara K,
Funakoshi T, Amagai M and Saya H: Periostin is a key niche
component for wound metastasis of melanoma. PLoS One.
10:e01297042015. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Wang Y, Li Q, Yang X, Guo H, Ren T, Zhang
T, Ghadakpour P and Ren F: Exosome-mediated communication in
thyroid cancer: Implications for prognosis and therapeutic targets.
Biochem Genet. 63:2673–2697. 2025. View Article : Google Scholar
|
|
162
|
Mouw JK, Ou G and Weaver VM: Extracellular
matrix assembly: A multiscale deconstruction. Nat Rev Mol Cell
Biol. 15:771–785. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Boulter L, Bullock E, Mabruk Z and Brunton
VG: The fibrotic and immune microenvironments as targetable drivers
of metastasis. Br J Cancer. 124:27–36. 2021. View Article : Google Scholar :
|
|
164
|
Sonnenberg-Riethmacher E, Miehe M and
Riethmacher D: Periostin in allergy and inflammation. Front
Immunol. 12:7221702021. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Tomasek JJ, Gabbiani G, Hinz B, Chaponnier
C and Brown RA: Myofibroblasts and mechano-regulation of connective
tissue remodelling. Nat Rev Mol Cell Biol. 3:349–363. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Xu X, Chang W, Yuan J, Han X, Tan X, Ding
Y, Luo Y, Cai H, Liu Y, Gao X, et al: Periostin expression in
intra-tumoral stromal cells is prognostic and predictive for
colorectal carcinoma via creating a cancer-supportive niche.
Oncotarget. 7:798–813. 2016. View Article : Google Scholar :
|
|
167
|
Ashley SL, Wilke CA, Kim KK and Moore BB:
Periostin regulates fibrocyte function to promote myofibroblast
differentiation and lung fibrosis. Mucosal Immunol. 10:341–351.
2017. View Article : Google Scholar :
|
|
168
|
Kiesler ZG, Hunter MI, Balboula AZ and
Patterson AL: Periostin's role in uterine leiomyoma development: A
Mini-review on the potential periostin poses as a pharmacological
intervention for uterine leiomyoma. Arch Gynecol Obstet.
309:1825–1831. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Jamaluddin MFB, Ko YA, Kumar M, Brown Y,
Bajwa P, Nagendra PB, Skerrett-Byrne DA, Hondermarck H, Baker MA,
Dun MD, et al: Proteomic profiling of human uterine fibroids
reveals upregulation of the extracellular matrix protein periostin.
Endocrinology. 159:1106–1118. 2018. View Article : Google Scholar
|
|
170
|
Nielsen SR, Quaranta V, Linford A, Emeagi
P, Rainer C, Santos A, Ireland L, Sakai T, Sakai K, Kim YS, et al:
Macrophage-secreted granulin supports pancreatic cancer metastasis
by inducing liver fibrosis. Nat Cell Biol. 18:549–560. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Clézardin P, Coleman R, Puppo M, Ottewell
P, Bonnelye E, Paycha F, Confavreux CB and Holen I: Bone
metastasis: Mechanisms, therapies, and biomarkers. Physiol Rev.
101:797–855. 2021. View Article : Google Scholar
|
|
172
|
Jackett KN, Browne AT, Aber ER, Clements M
and Kaplan RN: How the bone microenvironment shapes the
pre-metastatic niche and metastasis. Nat Cancer. 5:1800–1814. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Muscarella AM, Aguirre S, Hao X, Waldvogel
SM and Zhang XH: Exploiting bone niches: Progression of
disseminated tumor cells to metastasis. J Clin Invest.
131:e1437642021. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Baccin C, Al-Sabah J, Velten L, Helbling
PM, Grünschläger F, Hernández-Malmierca P, Nombela-Arrieta C,
Steinmetz LM, Trumpp A and Haas S: Combined single-cell and spatial
transcriptomics reveal the molecular, cellular and spatial bone
marrow niche organization. Nat Cell Biol. 22:38–48. 2020.
View Article : Google Scholar
|
|
175
|
Chen F, Han Y and Kang Y: Bone marrow
niches in the regulation of bone metastasis. Br J Cancer.
124:1912–1920. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Shafat MS, Gnaneswaran B, Bowles KM and
Rushworth SA: The bone marrow microenvironment-Home of the leukemic
blasts. Blood Rev. 31:277–286. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Weilbaecher KN, Guise TA and McCauley LK:
Cancer to bone: A fatal attraction. Nat Rev Cancer. 11:411–425.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Contié S, Voorzanger-Rousselot N, Litvin
J, Clézardin P and Garnero P: Increased expression and serum levels
of the stromal cell-secreted protein periostin in breast cancer
bone metastases. Int J Cancer. 128:352–360. 2011. View Article : Google Scholar
|
|
179
|
Gineyts E, Bonnet N, Bertholon C, Millet
M, Pagnon-Minot A, Borel O, Geraci S, Bonnelye E, Croset M, Suhail
A, et al: The C-terminal intact forms of periostin (iPTN) are
surrogate markers for osteolytic lesions in experimental breast
cancer bone metastasis. Calcif Tissue Int. 103:567–580. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Liu C, Feng X, Wang B, Wang X, Wang C, Yu
M, Cao G and Wang H: Bone marrow mesenchymal stem cells promote
head and neck cancer progression through Periostin-mediated
phosphoinositide 3-kinase/Akt/mammalian target of rapamycin. Cancer
Sci. 109:688–698. 2018. View Article : Google Scholar :
|
|
181
|
Ling W, Johnson SK, Mehdi SJ, Alapat DV,
Bauer M, Zangari M, Schinke C, Thanendrarajan S, van Rhee F and
Yaccoby S: EDNRA-expressing mesenchymal cells are expanded in
myeloma interstitial bone marrow and associated with disease
progression. Cancers (Basel). 15:45192023. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Terpos E, Christoulas D, Kastritis E,
Bagratuni T, Gavriatopoulou M, Roussou M, Papatheodorou A,
Eleutherakis-Papaiakovou E, Kanellias N, Liakou C, et al: High
levels of periostin correlate with increased fracture rate, diffuse
MRI pattern, abnormal bone remodeling and advanced disease stage in
patients with newly diagnosed symptomatic multiple myeloma. Blood
Cancer J. 6:e4822016. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Sun CY, Mi YY, Ge SY, Hu QF, Xu K, Guo YJ,
Tan YF, Zhang Y, Zhong F and Xia GW: Tumor- and Osteoblast-derived
periostin in prostate cancer bone metastases. Front Oncol.
11:7957122021. View Article : Google Scholar
|
|
184
|
Ma Z, Zhao X, Deng M, Huang Z, Wang J, Wu
Y, Cui D, Liu Y, Liu R and Ouyang G: Bone marrow mesenchymal
stromal cell-derived periostin promotes B-ALL progression by
modulating CCL2 in leukemia cells. Cell Rep. 26:1533–1543.e4. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Izuhara K, Nunomura S, Nanri Y, Ogawa M,
Ono J, Mitamura Y and Yoshihara T: Periostin in inflammation and
allergy. Cell Mol Life Sci. 74:4293–4303. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Kii I: Practical application of periostin
as a biomarker for pathological conditions. Adv Exp Med Biol.
1132:195–204. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Conway SJ, Izuhara K, Kudo Y, Litvin J,
Markwald R, Ouyang G, Arron JR, Holweg CT and Kudo A: The role of
periostin in tissue remodeling across health and disease. Cell Mol
Life Sci. 71:1279–1288. 2014. View Article : Google Scholar :
|
|
188
|
Lu S, Peng L, Ma F, Chai J, Hua Y, Yang W
and Zhang Z: Increased expression of POSTN predicts poor prognosis:
A potential therapeutic target for gastric cancer. J Gastrointest
Surg. 27:233–249. 2023. View Article : Google Scholar
|
|
189
|
Chu LJ, Tsai CJ, Chien CC, Hsiao YC, Yu
JS, Tsai JY and Yeh TS: Plasma POSTN derived from bile proteome is
a promising biomarker for cholangiocarcinoma with efficacy
comparable and complementary to CA19.9. United European
Gastroenterol J. 13:1155–1170. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Rachner TD, Göbel A, Hoffmann O, Erdmann
K, Kasimir-Bauer S, Breining D, Kimmig R, Hofbauer LC and Bittner
AK: High serum levels of periostin are associated with a poor
survival in breast cancer. Breast Cancer Res Treat. 180:515–524.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Dong D, Zhang L, Jia L, Ji W, Wang Z, Ren
L, Niu R and Zhou Y: Identification of serum periostin as a
potential diagnostic and prognostic marker for colorectal cancer.
Clin Lab. 64:973–981. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Lv Y, Wang W, Jia WD, Sun QK, Huang M,
Zhou HC, Xia HH, Liu WB, Chen H, Sun SN and Xu GL: High
preoparative levels of serum periostin are associated with poor
prognosis in patients with hepatocellular carcinoma after
hepatectomy. Eur J Surg Oncol. 39:1129–1135. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Fujimoto K, Kawaguchi T, Nakashima O, Ono
J, Ohta S, Kawaguchi A, Tonan T, Ohshima K, Yano H, Hayabuchi N, et
al: Periostin, a matrix protein, has potential as a novel
serodiagnostic marker for cholangiocarcinoma. Oncol Rep.
25:1211–1216. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Hu F, Shang XF, Wang W, Jiang W, Fang C,
Tan D and Zhou HC: High-level expression of periostin is
significantly correlated with tumour angiogenesis and poor
prognosis in osteosarcoma. Int J Exp Pathol. 97:86–92. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Villani R, Murigneux V, Alexis J, Sim SL,
Wagels M, Saunders N, Soyer HP, Parmentier L, Nikolaev S, Fink JL,
et al: Subtype-specific analyses reveal infiltrative basal cell
carcinomas are highly interactive with their environment. J Invest
Dermatol. 141:2380–2390. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Zhao Z, Mak TK, Shi Y, Li K, Huo M and
Zhang C: Integrative analysis of Cancer-associated fibroblast
signature in gastric cancer. Heliyon. 9:e192172023. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Kyutoku M, Taniyama Y, Katsuragi N,
Shimizu H, Kunugiza Y, Iekushi K, Koibuchi N, Sanada F, Oshita Y
and Morishita R: Role of periostin in cancer progression and
metastasis: Inhibition of breast cancer progression and metastasis
by anti-periostin antibody in a murine model. Int J Mol Med.
28:181–186. 2011.PubMed/NCBI
|
|
198
|
Zhu M, Saxton RE, Ramos L, Chang DD,
Karlan BY, Gasson JC and Slamon DJ: Neutralizing monoclonal
antibody to periostin inhibits ovarian tumor growth and metastasis.
Mol Cancer Ther. 10:1500–1508. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Lee YJ, Kim IS, Park SA, Kim Y, Lee JE,
Noh DY, Kim KT, Ryu SH and Suh PG: Periostin-binding DNA aptamer
inhibits breast cancer growth and metastasis. Mol Ther.
21:1004–1013. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Liu GX, Xi HQ, Sun XY and Wei B: Role of
periostin and its antagonist PNDA-3 in gastric cancer metastasis.
World J Gastroenterol. 21:2605–2613. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Halin Bergström S, Semenas J, Nordstrand
A, Thysell E, Wänman J, Crnalic S, Widmark A, Thellenberg-Karlsson
C, Andersson P, Gidlund S, et al: Morphological heterogeneities in
prostate cancer bone metastases are related to molecular subtypes
and prognosis. Clin Exp Metastasis. 49:422025.
|
|
202
|
Zeng L, Li L, Liao X, Zhang L, Yin C, Chen
X and Sun J: Population-based high-dimensional analyses identify
multiple intrinsic characters for cancer vaccines against lung
squamous cell carcinoma. Med Oncol. 41:422024. View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Ratajczak-Wielgomas K, Grzegrzolka J,
Piotrowska A, Matkowski R, Wojnar A, Rys J, Ugorski M and Dziegiel
P: Expression of periostin in breast cancer cells. Int J Oncol.
51:1300–1310. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
204
|
Yang T, Deng Z, Pan Z, Qian Y, Yao W and
Wang J: Prognostic value of periostin in multiple solid cancers: A
systematic review with Meta-analysis. J Cell Physiol.
235:2800–2808. 2020. View Article : Google Scholar
|
|
205
|
Li M, Ma G, Li X and Zhou Q: The
prognostic value of periostin expression in Non-small cell lung
cancer: A Meta-analysis. Med Sci Monit. 28:e9368982022. View Article : Google Scholar : PubMed/NCBI
|
|
206
|
Morra L, Rechsteiner M, Casagrande S, von
Teichman A, Schraml P, Moch H and Soltermann A: Characterization of
periostin isoform pattern in non-small cell lung cancer. Lung
Cancer. 76:183–190. 2012. View Article : Google Scholar
|
|
207
|
Utispan K, Sonongbua J, Thuwajit P,
Chau-In S, Pairojkul C, Wongkham S and Thuwajit C: Periostin
activates integrin α5β1 through a PI3K/AKT-dependent pathway in
invasion of cholangiocarcinoma. Int J Oncol. 41:1110–1118. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
208
|
Wu Y, Li S, Yu H, Zhang S, Yan L, Guan X,
Xu W, Wang Z, Lv A, Tian X, et al: Integrative Single-cell and
spatial transcriptomics analysis reveals ECM-remodeling
Cancer-associated Fibroblast-derived POSTN as a key mediator in
pancreatic ductal adenocarcinoma progression. Int J Biol Sci.
21:3573–3596. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Xue H, Gao X, Xu S, Zhang J, Guo X, Yan S,
Li T, Guo X, Liu Q and Li G: MicroRNA-Let-7f reduces the
vasculogenic mimicry of human glioma cells by regulating
periostin-dependent migration. Oncol Rep. 35:1771–1777. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
210
|
Yan S, Han X, Xue H, Zhang P, Guo X, Li T,
Guo X, Yuan G, Deng L and Li G: Let-7f inhibits glioma cell
proliferation, migration, and invasion by targeting periostin. J
Cell Biochem. 116:1680–1692. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
211
|
Wei T, Wang K, Liu S, Fang Y, Hong Z, Liu
Y, Zhang H, Yang C, Ouyang G and Wu T: Periostin deficiency reduces
PD-1+ tumor-associated macrophage infiltration and enhances
anti-PD-1 efficacy in colorectal cancer. Cell Rep. 42:1120902023.
View Article : Google Scholar
|
|
212
|
Zhang W, Wu FH, Wang J, Wei HZ, Wang TW
and Zhang YC: Periostin: A predictable molecule to prognosis and
chemotherapy responses of gastrointestinal and
hepato-biliary-pancreatic malignant tumors? Neoplasma. 69:491–503.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
213
|
Ishibashi Y, Mochizuki S, Horiuchi K,
Tsujimoto H, Kouzu K, Kishi Y, Okada Y and Ueno H: Periostin
derived from cancer-associated fibroblasts promotes esophageal
squamous cell carcinoma progression via ADAM17 activation. Biochim
Biophys Acta Mol Basis Dis. 1869:1666692023. View Article : Google Scholar : PubMed/NCBI
|
|
214
|
Mikheev AM, Mikheeva SA, Trister AD,
Tokita MJ, Emerson SN, Parada CA, Born DE, Carnemolla B, Frankel S,
Kim DH, et al: Periostin is a novel therapeutic target that
predicts and regulates glioma malignancy. Neuro Oncol. 17:372–382.
2015. View Article : Google Scholar :
|
|
215
|
Chen G, Nakamura I, Dhanasekaran R, Iguchi
E, Tolosa EJ, Romecin PA, Vera RE, Almada LL, Miamen AG,
Chaiteerakij R, et al: Transcriptional induction of periostin by a
sulfatase 2-TGFβ1-SMAD signaling axis mediates tumor angiogenesis
in hepatocellular carcinoma. Cancer Res. 77:632–645. 2017.
View Article : Google Scholar
|
|
216
|
Shang Y, Liang Y, Zhang B, Wu W, Peng Y,
Wang J, Zhang M and Niu C: Periostin-mediated activation of NF-κB
signaling promotes tumor progression and chemoresistance in
glioblastoma. Sci Rep. 15:139552025. View Article : Google Scholar
|
|
217
|
Wu J, Li J, Xu H, Qiu N, Huang X and Li H:
Periostin drives extracellular matrix degradation, stemness, and
chemoresistance by activating the MAPK/ERK signaling pathway in
triple-negative breast cancer cells. Lipids Health Dis. 22:1532023.
View Article : Google Scholar : PubMed/NCBI
|
|
218
|
Wang Y, Wang B, Cao W and Xu X: PTX3
activates POSTN and promotes the progression of glioblastoma via
the MAPK/ERK signalling axis. Biochem Biophys Res Commun.
703:1496652024. View Article : Google Scholar : PubMed/NCBI
|
